Comparison of the Baseline Cardiovascular Risk Profile Among Hypertensive Patients Prescribed COX-2-Specific Inhibitors or Nonspecific NSAIDs: Data From Real-Life PracticeBySean Z. Zhao, MD, PhD,Thomas A. Burke, PharmD, MPH,Andrew Whelton, MD, PhD,Heather von Allmen,Scott C. Henderson, MSOctober 1st 2002
Blood Pressure Destabilization and Related Healthcare Utilization Among Hypertensive Patients Using Nonspecific NSAIDs and COX-2-Specific InhibitorsBySean Z. Zhao, MD, PhD,Thomas A. Burke, PharmD, MPH,Andrew Whelton, MD, PhD,Heather von Allmen,Scott C. Henderson, MSOctober 1st 2002
Cost of Heart Failure Among Hypertensive Users of Nonspecific NSAIDs and COX-2-Specific InhibitorsBySean Z. Zhao, MD, PhD,Thomas A. Burke, PharmD, MPH,Andrew Whelton, MD, PhD,Heather von Allmen,Scott C. Henderson, MSOctober 1st 2002
